Get started
BioHarvest Sciences Inc.BB

BioHarvest Sciences Inc.

6.56USDR
+0.10+1.63%
At close at Mar 28, 19:49 GMT
USD
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

BHST fundamentals

Key facts

Market capitalization‪96.32 M‬USD
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)−1.21USD
Founded2013
Employees (FY)—
CEOIlan Sobel
Websitebioharvest.com
About

BioHarvest Sciences, Inc. develops bio-cell growth platform technology. The firm engages in botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions. It offers nutraceutical health and wellness products, which includes dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients. The company was founded on April 19, 2013 and is headquartered in Vancouver, Canada.

Ownership
‪‪17.33 M‬‬
Free Float shares
‪‪12.14 M‬‬ (70.08%)
Closely held shares
‪‪5.18 M‬‬ (29.92%)
Free Float shares
‪‪12.14 M‬‬ (70.08%)
Closely held shares
‪‪5.18 M‬‬ (29.92%)
Capital structure
Market cap
‪‪96.32 M‬‬
Debt
‪‪12.93 M‬‬
Cash & equivalents
‪‪2.76 M‬‬
Enterprise value
‪‪106.48 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪96.32 M‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
4.29x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
4.29x
Valuation ratios
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪1.60‬
‪3.20‬
‪4.80‬
‪6.40‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−170%‬
‪−130%‬
‪−90%‬
‪−50%‬
‪−10%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−8.00 M‬‬
‪‪−4.00 M‬‬
‪0.00‬
‪‪4.00 M‬‬
‪‪8.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−3.00 M‬‬
‪0.00‬
‪‪3.00 M‬‬
‪‪6.00 M‬‬
‪‪9.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−3.00 M‬‬
‪0.00‬
‪‪3.00 M‬‬
‪‪6.00 M‬‬
‪‪9.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Nutraceuticals
By country
Period: 2023
United States
Israel

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪2.10 M‬‬
‪‪4.20 M‬‬
‪‪6.30 M‬‬
‪‪8.40 M‬‬
Actual
Estimate
Earnings
Next:May 28, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪−0.52‬
‪−0.39‬
‪−0.26‬
‪−0.13‬
‪0.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

BHST does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−9.00 M‬‬
‪0.00‬
‪‪9.00 M‬‬
‪‪18.00 M‬‬
‪‪27.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪5.00 M‬‬
‪‪10.00 M‬‬
‪‪15.00 M‬‬
‪‪20.00 M‬‬
Assets
Liabilities